SCHEMBL470411

SCHEMBL470411

Bc1cc2nc(C)c(C(O)C(=O)OC)c(Cl)n2n1

nearest known ligand 0.32

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.32
ALDH1A1 P00352 2/20 0.32
HPGD P15428 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
HSD17B10 Q99714 2/20 0.32
MAPT P10636 2/20 0.32
NPC1 O15118 1/20 0.32
USP2 O75604 1/20 0.32
MAPK1 P28482 1/20 0.32
HTT P42858 1/20 0.32
RAB9A P51151 1/20 0.32
LMNA P02545 1/20 0.32
TP53 P04637 1/20 0.31
PIK3CG P48736 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17020424 0.86 SMN1; SMN2 (0.33) KDM4EALDH1A1HPGDSMN1; SMN2HSD17B10
SCHEMBL460915 0.86 SMN1; SMN2 (0.33) KDM4EALDH1A1HPGDSMN1; SMN2HSD17B10
SCHEMBL470426 0.84 NR1I2 (0.33) KDM4EALDH1A1HPGDSMN1; SMN2HSD17B10
SCHEMBL457888 0.81 MAPT (0.47) KDM4EALDH1A1HPGDSMN1; SMN2HSD17B10
SCHEMBL458967 0.78 DPP4 (0.45) KDM4EALDH1A1HPGDSMN1; SMN2HSD17B10
SCHEMBL458966 0.78 DPP4 (0.45) KDM4EALDH1A1HPGDSMN1; SMN2HSD17B10
SCHEMBL15476277 0.77 NPC1 (0.51) KDM4EALDH1A1HPGDSMN1; SMN2HSD17B10
SCHEMBL15476278 0.77 NPC1 (0.51) KDM4EALDH1A1HPGDSMN1; SMN2HSD17B10
SCHEMBL461275 0.75 NPC1 (0.40) KDM4EALDH1A1HPGDSMN1; SMN2HSD17B10
SCHEMBL461782 0.75 NPC1 (0.40) KDM4EALDH1A1HPGDSMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012033735-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-15 WO disclosed